Oxidation of a tyrosine kinase inhibitor vandetanib by human cytochromes P450 and flavin monooxygenases in vitro and its effect of DNA adduct formation mediated by an anticancer drug ellipticine
FEBS OPEN BIO
Indra, R; Pompach, P; Takacsova, P; Vavrova, K; Heger, Z; Adam, V; Eckschlager, T; Kopeckova, K; Stiborova, M, 2018: Oxidation of a tyrosine kinase inhibitor vandetanib by human cytochromes P450 and flavin monooxygenases in vitro and its effect of DNA adduct formation mediated by an anticancer drug ellipticine. FEBS OPEN BIO 8, p. 350 - 350
CEITEC authors: